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Synchrotron X-ray nanomechanical imaging
Nanoscale deformation mechanisms
Multiscale mechanical modellingGlucocorticoid-induced osteoporosis (GIOP) is a major secondary form of osteoporosis, with the fracture
risk significantly elevated – at similar levels of bone mineral density – in patients taking glucocorticoids
compared with non-users. The adverse bone structural changes at multiple hierarchical levels in GIOP,
and their mechanistic consequences leading to reduced load-bearing capacity, are not clearly understood.
Here we combine experimental X-ray nanoscale mechanical imaging with analytical modelling of the
bone matrix mechanics to determine mechanisms causing bone material quality deterioration during
development of GIOP. In situ synchrotron small-angle X-ray diffraction combined with tensile testing
was used to measure nanoscale deformation mechanisms in a murine model of GIOP, due to a
corticotrophin-releasing hormone promoter mutation, at multiple ages (8-, 12-, 24- and 36 weeks), com-
plemented by quantitative micro-computed tomography and backscattered electron imaging to deter-
mine mineral concentrations. We develop a two-level hierarchical model of the bone matrix
(mineralized fibril and lamella) to predict fibrillar mechanical response as a function of architectural
parameters of the mineralized matrix. The fibrillar elastic modulus of GIOP-bone is lower than healthy
bone throughout development, and nearly constant in time, in contrast to the progressively increasing
stiffness in healthy bone. The lower mineral platelet aspect ratio value for GIOP compared to healthy
bone in the multiscale model can explain the fibrillar deformation. Consistent with this result, indepen-
dent measurement of mineral platelet lengths from wide-angle X-ray diffraction finds a shorter mineral
platelet length in GIOP. Our results show how lowered mineralization combined with altered mineral
nanostructure in GIOP leads to lowered mechanical competence.
Significance Statement
Increased fragility in musculoskeletal disorders like osteoporosis are believed to arise due to alterations
in bone structure at multiple length-scales from the organ down to the supramolecular-level, where col-
lagen molecules and elongated mineral nanoparticles form stiff fibrils. However, the nature of these
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stiffness linked to altered bone mineral qualityfibrils deform in secondary osteoporosis, as well as how the fibril orientation and mineral nanoparticle
structure changes. We found that osteoporotic fibrils become less stiff both because the mineral nanopar-
ticles became shorter and less efficient at transferring load from collagen, and because the fibrils are more
randomly oriented. These results will help in the design of new composite musculoskeletal implants for
bone repair.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The reduced mechanical and structural competence of bone in
musculoskeletal disorders (e.g. osteoporosis and osteoarthritis)
arise from both alterations in the mineralization dynamics (via
altered cellular activity) as well as intrinsic changes in the
mineralized collagen matrix (as in disorders like osteogenesis
imperfecta), but the mechanisms linking matrix alterations to
reduced functionality are not always clear [1–4]. Glucocorticoid-
induced osteoporosis (GIOP) is one of such disorders, affects
1–3% of the general population and is characterised by a rapid
increase in fracture risk in patients taking anti-inflammatory ster-
oidal medications (glucocorticoids or GCs) [5–8]. About 30 to 50
percent of patients with chronic glucocorticoid treatment suffer
from osteoporotic fractures [9]. In cancellous bone, GCs can cause
suppression of bone formation and enhanced and prolonged
resorption through direct effects on osteoblasts, osteoclasts and
osteocytes [10,11]. As a result, in GIOP, bone resorption (osteoclas-
tic activity) is not matched by bone formation (osteoblastic activ-
ity), which results in reduced bone mass. Most notably, however,
the increase in fracture risk in GIOP is larger than predicted from
changes in bone mass alone (relative to healthy bone) [12], imply-
ing that changes in the bone matrix and microarchitecture play an
important role. For example, increased vertebral fracture risk in
GIOP-patients is associated with trabecular thinning (microarchi-
tecture), and material-level changes have been observed as well
in cancellous bone [13–15]. Alterations in bone metabolism –
mainly affecting cancellous bone – in terms of cellular changes
have been recognized in GIOP [1,16]. Therefore, understanding
the structural mechanisms in bone tissue – at multiple hierarchical
levels – which cause the reduction in mechanical properties in
GIOP would thus be of considerable clinical relevance. Such an
understanding would also shed light on the mechanical relevance
of bone matrix quality [3,4,17] in a prototypical example of
secondary osteoporosis, where the current gold standard method
of assessment of osteoporotic fracture risk – bone mineral density
or BMD [18–20] – is inadequate for fracture risk predictions
[5,12,21].
The cellular mechanisms of action of GIOP include disruption of
theWnt/LRP5 signalling pathway, leading to reduction of new bone
formation, via osteoblastic suppression and increased osteoblast
apoptosis [12,22]. Further, GC action prolongs osteoclast lifespan,
which leads to greater bone resorption [11]. More recently,
researchers have focused on the alteration in osteocyte metabo-
lism, which leads to local demineralization around lacunae
[23,24]. However, the structural mechanisms by which these
cellular-level changes reduce mechanical competence remains to
be elucidated. In postmenopausal women treated with GCs,
reduced bone formation led to trabecular thinning [14,15], and
an increased fracture risk when compared to untreated patients
with similar bone mineral density (BMD) [12]. At the microscale,
alteration of the resorption cavities in GIOP from rounded to elon-
gated shapes have been shown, via finite element modelling, to
explain in part the stiffness reduction in GIOP [25]. The use of
quantitative computed tomography – rather than DXA-based
BMD measurements – was found to better explain male vertebralne matrix development in stero
, Acta Biomater. (2018), https:/fracture in GIOP [26], further highlighting the importance of
micro-architectural changes in bone quality. Studies using micro
computed tomography (micro-CT) showed that GCs treatment
results in a reduced number, volume and connectivity of trabecu-
lae and reduced cortical thickness in patients [13,27]. GCs treated
mice showed larger osteocyte lacunae surrounded by ‘‘halos” of
hypomineralized bone tissue with 30–40% reduction in local
bone mineralization compared to normal mice, as well as loss of
trabecular bone volume [13,28].
At the level of the mineralized bone matrix (‘‘material” level
[3,4]), however, relatively few studies exist, and the link between
the growth and development of an altered bone matrix and the
change in material-level mechanics is unexplored. Material-level
changes in bone matrix quality – whether via increased collagen
crosslinking in ageing human bone [29], reduced extrafibrillar
mineralization in rickets [30], or via actions of anti-osteoporotic
drugs [31] have been demonstrated in several different bone
pathologies, and it is hence likely that GIOP-bone is associated
with such changes as well. In this regard, a few studies have shown
that the stiffness of the bone matrix also reduces in GIOP [13,32].
For example, localized atomic force microscopy and nanoindenta-
tion data on mice bone show that tissue regions around osteocytes
have both lower mineralization (hypomineralized ‘‘haloes”) as well
as elastic modulus [13]. Our group explored the link between such
mechanical changes and structural deformation mechanisms at the
fibrillar level [32] using in situ X-ray nanomechanics. We used syn-
chrotron small-angle X-ray diffraction (SAXD) to measure the
deformation of the mineralized collagen fibrils in GIOP bone, and
found reductions in fibrillar-level moduli and increased random-
ness in fibrillar orientation at a single age-point in a murine model
of GIOP. The model arises from a corticotrophin-releasing hormone
(Crh) promoter mutation that was associated with elevated plasma
and urinary concentrations of corticosterone in mutant heterozy-
gous mice (Crh120/+) when compared to wild-type (WT) mice
(Crh+/+) [32,33]. Most recently, Fowler and co-workers have also
shown that glucocorticoid-treated mice exhibited a disorganized
fibrillar structure and matrix hypermineralization in murine sub-
chondral bone [34]. Despite these recent experimental advances,
both (a) the developmental- and age-related changes in bone
matrix quality in GIOP and (b) structural models of the alterations
in the mineralized collagen nanostructure leading to such reduc-
tions in mechanics have been very little studied.
In this study, we hypothesize that GIOP leads to a consistent
reduction of the nanoscale fibrillar mechanics of bone throughout
development, and that alterations in the mineralized fibrillar archi-
tecture – beyond overall mineral content – can be implicated in
these reductions. Combining in situ X-ray nanomechanical imaging
using SAXD, microcomputed tomography, micromechanical mod-
elling and wide-angle X-ray diffraction of the mineral crystallite
phase, we quantify the changes in bone matrix quality at multiple
age points during tissue development in a Crh120/+ mice, which are
a model of Cushing’s syndrome. We use Cushing’s syndrome
(endogenous production of corticosteroids) as a model for GIOP,
as there is similar fracture risk associated with endogenous pro-
duction and exogenous administration of corticosteroids [16].
The aim of the study was to clarify whether the changes in boneid-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
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with tissue maturation, and how the altered mechanical properties
could be interpreted via a structural model of the mineralized fibril
arrays at the nano- and micro-level.2. Materials and Methods
2.1. Animals
Bone tissue from female Crh120/+ mice on a C57BL/6 genetic
background (3rd generation) and Crh+/+ littermates aged 8, 12, 24
and 36 weeks were studied. Mouse samples were stored at 20
C before experiments. The mice were bred as part of a prior study
[33], where all animal studies were carried out using guidelines
issued by the UK Medical Research Council, in Responsibility in
Use of Animals for Medical Research (July 1993) and Home Office
Project License numbers 30/2433 and 30/2642.
2.2. Sample preparation for in-situ tensile testing
Bone samples were prepared for in situ microtensile testing, as
described previously [30]. Longitudinal sections of murine femora
were prepared using a water-irrigated low speed diamond saw
(Fig. 1A). The distal and proximal ends of anterior femora strips
were secured in dental ionomer such that samples could be
mounted in the microtensile tester (Fig. 1B, C). The dental ionomer
was treated for 20s with UV light exposure while the mid-
diaphysis of bone was covered by lead tape during UV light expo-
sure to prevent any UV-induced tissue alteration. The typical gauge
length of bone samples was 5–6 mm in length, 1 mm in width
and 0.2 mm in thickness. The total length of the femora were9–
10 mmwith 4 mm of the bone distal and proximal ends embedded
in dental ionomer. Post-embedding, Vernier calipers were used to
carefully measure the distance between dental ionomer moulds
to determine gauge length for each sample. Samples were then
wrapped in PBS-soaked tissue paper and stored at 20 C before
used for mechanical testing. Number of samples tested at 8, 12,
24 and 36 weeks were 5, 9, 7 and 7, respectively, for Crh+/+ mice;
and 6, 10, 6, and 4, respectively, for Crh120/+ mice. The unequal
number of samples are because some samples were broken or
otherwise damaged while mounting in the tester during the
beamtime.
2.3. In-situ microtensile testing with synchrotron X-Ray scattering and
diffraction
In-situ tensile testing combined with real time synchrotron
SAXD were used to measure macroscopic tissue strain et (from
non-contact video extensometry) and fibril strain ef (from SAXD
frames) concurrently, as reported by Gupta et al. [35]. The merid-
ional stagger D of collagen molecules in bone fibrils leads to an
axial diffraction pattern in the SAXD region of reciprocal space.
The third order meridional collagen reflection was used to measure
the D-period. The fibril strain ef was calculated from the percent-
age increases in D-period during tensile testing of bone [29,35,36].
Samples were loaded uniaxially in tension using a customized
microtensile tester (Fig. 1B) which was mounted on a two-axis
motorized stage at Beamline I22, Diamond Light Source, UK. Sam-
ples were loaded in a fluid chamber, which provided a physiologi-
cal environment (PBS solution, room temperature) for the bone.
Motor strain was measured using a DC linear-encoder stage
(M112.1DG; Physic Instruments, UK) and load data was recorded
using a tension/compression load cell (model SLC31/00025 with
111 N range; RDP Electronics Ltd, UK). A waterproof marker with
0.05 mm tip from a pen (Copic multiliner, Too Corporation, Japan)Please cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/was used to make optical markers on the bone mid-diaphysis and a
Basler Ace USB Camera (MultiPix Imaging Components Ltd, UK)
was used to acquire consecutive images of samples with frame rate
of 5 fps during tensile loading. Tissue strain et was measured as
percent increase of distance between two horizontal optical mark-
ers on the bone during loading. Custom software written in Lab-
VIEW 2013 (National Instruments, UK) was used to control the
DC linear-encoder stage, load cell and camera such that motor
strain, load data and images were collected concurrently at 0.2 s
intervals during mechanical loading. Samples were loaded to fail-
ure using a constant velocity of 0.002 mm/s, corresponding to a
strain rate of 0.0004 s1, used in our previous studies [30,32,37,38].
A synchrotron X-ray beam with wavelength of 0.8857 Å and
beam cross section of  10 lm  10 lm at the sample was used
to measure the SAXD and WAXD patterns. The patterns were
acquired using a Pilatus P3-2 M detector [39] (Fig. 1D) with pixel
resolution of 1475  1679 pixels and pixel size of 172  172
lm2. The sample-to-detector distance for SAXD patterns was
1000 mm as measured with a silver behenate standard. The
sample-to-detector distance for WAXD patterns was 175 mm as
measured with a silicon standard. A SAXD pattern with an expo-
sure time of 0.5 s was collected every 10 s during tensile loading
up to failure. In order to minimize the absorption of X-ray scatter-
ing in the fluid, the physiological fluid chamber was designed with
4 mm total X-ray path length in the PBS solution. To reduce the
effects of X-ray radiation on the bone mechanical properties, the
X-ray shutter was closed between exposures [40].
2.4. Small angle X-ray scattering (SAXS) and diffraction (SAXD) data
analysis
2D SAXD patterns of mice bones acquired during tensile testing
were used for calculation of fibril D-period and fibril strain ef. The
data analysis software package DAWN [41,42] (www.dawnsci.org)
was used in conjunction with a customised Python script for SAXD
data analysis. 2D SAXD frames were radially integrated over 20
angular sectors centred along the loading direction to get 1D inten-
sity profiles around the third-order reflection of collagen. Then, the
obtained 1D profiles were automatically fitted using a custom
script, which was added as a Python XY-to-XY operation to the Pro-
cessing pipeline in DAWN [42]. A Gaussian peak combined with a
linear background term were used for the peak fitting of the
third-order reflection from collagen fibrils. The obtained peak posi-
tions were used to calculate the meridional stagger D-periods of
collagen fibrils, and fibril strains were measured from the percent-
age changes of collagen D-periods during tensile loading relative to
the unstrained state. The effective fibril modulus (Ef = dr/def) was
defined as the slope of tissue-level stress versus fibril strain from
the elastic region of deformation, following prior work [30,32].
2.5. Determination of degree of fibrillar alignment
Degree of alignment of the mineral crystals (the q-parameter)
can be determined from angular SAXD intensity profiles following
previous work [43–46]. The intensity distribution obtained from
azimuthal integration of the SAXD pattern shows two peaks sepa-
rated by 180. Parallel-aligned particles contribute to the area
under the peaks, whereas randomly oriented particles contribute
to the area under the constant background. The q-parameter is
defined as q = (area under the peaks)/(total area) [43–46].
Perfectly-parallel aligned mineral platelets will give a narrow
streak perpendicular to the long axis of the mineral particles on
the SAXD pattern giving a q-parameter of 1, randomly oriented
particles will give a spherical SAXD pattern (q = 0), and partially
aligned mineral crystals will give an elliptical SAXD pattern (0 <
q < 1). In this work, the mineral platelets will be taken as parallelid-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
Fig. 1. Experimental configuration for in situ nanomechanics with synchrotron SAXD: (A) Schematic of mouse femur, with tensile test specimen sectioned along the long axis
of femur. (B) Tensile tester with bone sample mounted along the X-ray beam path in transmission geometry. (C) Magnified view of sample and tensile grips in fluid chamber,
with tensile strain along the vertical direction. (D) Si pixel detector used for acquiring SAXD pattern from incident X-ray beam interacting with bone sample. (E) Typical stress
- tissue strain and (F) fibril strain – tissue strain plots for femoral mid-shaft of Crh+/+ and Crh120/+ mice aged 36 weeks. Straight lines indicate linear regression (R2 = 0.55 for
Crh+/+ (dashed) and R2 = 0.84 for Crh120/+ (dash-double dot)).
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q-parameter can be taken as a proxy for the degree of collagen fib-
rillar alignment. Due to a relatively lower SAXD signal intensity for
the azimuthal profile of the meridional reflections, it was decided
to use the higher-intensity diffuse scattering angular SAXS profile
for fibrillar alignment, in preference to the full width at half max-
imum of the angular meridional SAXD profile used earlier [32].2.6. Wide angle X-ray diffraction (WAXD) data analysis
The crystallographic structure of the mineral particles in bone
consist of hexagonal cubic apatite with the c-axis predominantly
oriented along the fibril direction [48]. The lattice spacing was cal-
culated from the (0 0 2) peak centre position of apatite along the
vertical direction in the WAXD region of reciprocal space [35]. A
Lorentzian function was used to fit the peak and obtain the full
width at half maximum (FWHM) of the (0 0 2) reflection (Figure S2,
Supplementary Information). The mean crystallite length of the
mineral phase in bone was calculated by Scherrer’s equation
[45,49]: L = kk/B cos h, where L is the mean mineral crystal length;
k is a constant related to the crystallite shape and falls in the range
0.87–1.0; k is the wavelength of the X-rays (0.8857 Å). B is the
FWHM of the (0 0 2) reflection of hydroxyapatite (HA) fromPlease cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/wide-angle X-ray diffraction (WAXD) patterns, and h is the Bragg
angle of the (0 0 2) reflection.
The broadening of the Debye-Scherrer width (0 0 2) reflection of
HA, as measured from WAXD pattern, has two main contributions
[45]: BL, the crystallite length contribution to the peak broadening,
and BI, the instrumental broadening contribution. B is expressed as
a squared sum function of these contributions: B2 = BL2 + BI2. The
instrumental broadening contribution on the HA crystallite was
estimated by calculating the FWHM at a wavevector (q) value of
(0 0 2) reflection from the linear regression of FWHM - q plot for
a Si standard. All measured FWHM of (0 0 2) reflection were then
corrected with respect to the instrumental broadening contribu-
tion to obtain BL, which is the mean mineral crystal length
(L-parameter).2.7. Backscattered electron imaging
Backscattered electron (BSE) imaging was used to measure the
two-dimensional (2D) morphology of the transverse cross section
of tibia mid-diaphysis. Three tibias from each age and disease con-
ditions were dehydrated in a graded series of ethanol and xylene
and then embedded in a histological embedding poly-methyl-
methacrylate (PMMA; three grams of azo-iso-butyronitrile per litreid-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
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tioned using a low-speed diamond saw and polished with grinding
papers and diamond liquid suspension with progressively finer
grain size down to 1 lm, as previously reported [37,38]. The final
polished surface was a transverse cross section in the mid-
diaphysis of tibia. A thin conductive carbon was coated to the sam-
ples surfaces before BSE imaging. The BSE imaging was performed
with a Scanning Electron Microscope (Inspect F, FEI Ltd, Eindhoven,
the Netherlands) equipped with a back-scattering detector. The
accelerating voltage was adjusted to be 20 kV and the current to
be 160 lA. Sample-to-detector distance was adjusted to be 10
mm for all BSE images. The obtained BSE images had pixel resolu-
tion of 1024  884 pixels with pixel size of 0.3125 lm. Each BSE
image had a range of gray levels from 0 to 255.
2.8. X-ray microtomography
Mice femur samples (cut samples already tested by in situ
microtensile testing) were used again for X-ray microtomography.
Three samples at each age point and genotype were used to obtain
tomograms and to calculate mean mineral concentration (degree
of mineralization) in the tissue at the microscale. X-ray microto-
mography was performed using a high-definition MuCat scanner
[50] equipped with an X-tek ultrafocus X-ray generator (Nikon
Metrology, Leuven, Belgium) and Spectral Instruments (Tucson,
Arizona, USA) 800 series CCD camera in a time-delay integration
readout mode. An accelerating voltage of 40 kV was used for the
scanning to obtain tomograms with voxel size of 15  15  15
lm3. The micro-CT projection data were calibrated to 25 keV
monochromatic equivalence and then reconstructed to form a 3D
image using a cone-beam back-projection algorithm. The 3D
images was converted to a stack of 2D images, and averaged using
the Tomview in-house software, which reports the linear attenua-
tion coefficient associated with the gray-level at each voxel in the
tomogram. The calculation of the mean mineral concentration in
bone using the following relation:
Mineral concentration ¼ l
lm
qm
Here, l is the measured linear attenuation coefficient and lm is the
mass attenuation coefficient of pure mineral, which is assumed to
be calcium hydroxyapatite (lm = 3.48 cm2g1, from the XCOM data-
base [51]). The attenuation from any residual organic component
could not be determined but was assumed to be negligible (even
in a hydrated state it is much lower than the mineral component).
Quantitative analysis of the mean mineral concentration (in units of
g/cm3) from tomograms were carried out for Crh+/+ mice, periosteal
and endosteal regions of Crh120/+ mice with increasing develop-
mental age. The mean mineral concentration is only calculated for
the bone tissue, excluding the spaces and voids around and within
the sample, by using a gray-level threshold midway between the
peaks in the gray-level histogram corresponding to the tissue and
corresponding to voids/empty space. Three regions of interest, com-
prising cortical bone in Crh+/+ femora, periosteal regions away from
cavities and endosteal regions near cavities in Crh120/+ femora,
were used to generate the histogram of mineral concentration
(Fig. 4D) using ImageJ software (ImageJ, NIH, USA). The obtained
histogram of mineral concentration was used to calculate the
weighted mean mineral concentrations, which was plotted against
age for three different regions (Fig. 4E,F).
2.9. Calculation of microscale porosity
The experimental stress data were post-multiplied by the coef-
ficient 1/(1  p3/2) to incorporate the effects – on the effective
cross-sectional area – of a 3D isotropic distribution of internalPlease cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/porosity in bone. In this case the 3D porosity is p3/2, where p is
the 2D porosity coefficient. The 2D porosity coefficient p is calcu-
lated via the following relation:
p ¼ 2Dareaof voids
2Darea of solid boneþ 2Darea of voids
2D area of voids and solid bone was analysed from 2D image
slices of X-ray tomographic data using segmentation tools in Avizo
software (Visualization Sciences group, Burlington, MA, USA). Gray
level based thresholding was manually chosen using Avizo such
that the voids and solid bone were completely segmented. The
total pixel number located in voids region and solid bone region
were used to obtain 2D area of voids and solid bone, respectively
(refer to Fig. S1, Supplementary Information (SI) for an example).
2.10. Statistical analysis
The variables in our experiment are bone type (Crh+/+ or
Crh120/+) and age (8, 12, 24 and 36 weeks). To test age-related
variation in tissue modulus, and nanoscale parameters like
effective fibril modulus, lattice spacing, FWHM, L-parameter, and
q-parameter, we carried out one-way ANOVA for each bone type
as a function of age followed by Tukey’s honestly significant differ-
ence (HSD) post hoc tests. To compare these same parameters as a
function of bone-type at each age, Student’s t-tests were used.
Lastly, for the sole case of mean mineral concentration, which
can be measured from three types of bone tissue (Crh+/+, Crh120/+-
ER (endosteal) and Crh120/+-PR (periosteal)) at each age, one-way
ANOVA tests were performed at each age when three different
regions were considered, and t-tests when the Crh120/+ tissue
was considered as a whole.
We note that a two-way ANOVA was not performed (with age
and bone-type as variables) due to unequal sample sizes between
ages and bone types. Further, to avoid overcrowding the Results
figures, the t-test indicators of significance are shown via pairwise
comparisons, while the more numerous pairwise post-hoc results
of age-related variation are summarized in the Results text, and
given in tables in the Supplementary Information in full. Excel
(Microsoft Office 2016) was used for the Student’s t-test and Sigma
Plot version 14.0 (Systat Software, San Jose, California) for the
ANOVA tests.
2.11. Modelling of bone matrix mechanics
We modelled the lamellar structure of bone as layers of miner-
alized fibrils. Specifically, at the nanometre scale, the mineralized
fibrils are made of mineral platelets that are embedded in a colla-
gen matrix (both materials mechanically isotropic) and arranged in
a staggered configuration, similar to previously described nanos-
cale models [52–55]. These fibrils form, at a higher hierarchical
level (micro-scale), a plywood lamellar system, also known as a
Bouligand or rotated plywood structure [56], made of several lay-
ers (sub-lamellae or laminae, in engineering terms [57]) arranged
as a stack and mechanically orthotropic (Fig. 2A). Specifically, the
thickness of the lamellar structure is 10 lm while the thickness
of each of the 100 sub-layers forming the structure is 100 nm.
The effective mechanical properties at the lamellar level were
calculated using lamination theory for composites [57]. In detail,
the modulus of each lamina (or sub-lamella) along the fibril direc-
tion (E1) was obtained by homogenizing the material properties of
the fibril using the constitutive relation for mineralized fibrils [55].
This relation takes into account the staggered arrangement of min-
eral platelets, their aspect ratio (AR) and their volume fraction. For
the laminar modulus E2 transverse to the fibril, and the laminar
shear modulus G12, the Reuss model (fibres and matrix arranged
in layers perpendicular to loading direction) was used. Lastly, theid-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
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of mixtures. All the material parameters as well as the relevant
equations at the laminar level implemented are included in the
Supplementary Information. Based on these input parameters,
the longitudinal elastic modulus of the entire lamella (along the
0 sublamella) was calculated from standard lamination theory
[57]. This parameter is compared against the effective fibril modu-
lus Ef obtained from the in situ SAXD experiments.
The discretization provided by the plywood model in [58] (set
of laminae of different thickness and angularly separated by 30)
was adopted in order to model the angular arrangement of laminae
(Fig. 2B). The lamination sequence of the plywood system was cal-
culated through a three-step process. Firstly, for a series of simu-
lated azimuthal I(v) plots with increasing FWHM (full width at
half maximum), the q-parameter (described in Section 2.5) was
calculated and plotted versus FWHM (Fig. 2C). Secondly, from the
experimentally obtained q-parameters (calculated as in 2.5), an
average value was chosen for each bone-type, and the equivalent
FWHM calculated. Normalized Gaussian curves with these
FWHM’s were calculated for each bone type (Fig. 2D shows a curve
for Crh+/+). By discretizing the Gaussian curve, as shown in Fig. 2D,
the relative proportions of fibrils at 0, ±30 and ± 60 were
obtained. These lamellar structural parameters were input into
the lamination theory model, and the numerical results were fitted
to the experimental data by varying the aspect ratio AR of the min-
eral particles in both cases.Fig. 2. Multiscale model of lamellae of mineralized fibrils: A) Plywood structure modell
made of mineralized fibrils). B) Discretization of the rotated plywood model we assumed
C) q-parameter vs FWHM. We assumed (from Fig. 6D) an average value of q for the Crh
values FWHM = 48 and 57. D) Example of normalized Gaussian curve used to calcu
determined from Fig. 2C. The area behind the central region of the curve is 74% of the tota
2% of ±60 laminae (considering right and left areas of the Gaussian curve). Analogous p
±30 and 6% of ±60 laminae. E) By fitting the analytical model with the experimental d
calculated (respectively, 15.0 for the Crh+/+ case and 9.6 for the Crh120/+ case).
Please cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/3. Results
3.1. In-situ tensile testing with synchrotron SAXD
Typical stress-tissue strain and fibril strain – tissue strain plots
for femoral mid-shaft of Crh+/+ and Crh120/+ mice aged 24 weeks
are shown in Fig. 1E, F. Considering deformation at the fibrillar
level, the combined data sets for macroscopic stress versus nanos-
cale fibrillar strain (Fig. 3A–D) in the elastic deformation region for
both Crh120/+ and Crh+/+ mice at each age points revealed differ-
ences in the slope, which was defined as the effective fibril modu-
lus (Ef = dr/def). All samples with the same genotype and
developmental age were plotted together using the same symbol.
Black solid and gray hollow scattering symbols represent Crh+/+
and Crh120/+ mice, respectively. Black and gray straight lines indi-
cate regressions of all data points in each group for Crh+/+ and
Crh120/+ mice, respectively.
The average effective fibril modulus was plotted as a function of
genotype and age, as shown in Fig. 3F. As age increased from 8 to
36 weeks, the effective fibril modulus increased by 12.7 GPa (from
9.5 to 22.2 GPa) in Crh+/+ mice, whereas it only increased by 1.6 GPa
(from 4.8 to 6.4 GPa) in Crh120/+ mice. At each age point, the effec-
tive fibril modulus was significantly lower in Crh120/+ mice as
compared with Crh+/+ mice. There is a statistically significant differ-
ence (p < 0.001) among 4 ages for effective fibril modulus in Crh+/+
mice, but none in Crh120/+ mice. In Crh+/+ mice, the significanted as a laminate composite (homogenized plywood structure where each lamella is
[58], with a set of lamellae of different thickness which are angularly shifted of 30.
+/+ bone of 0.45 and of 0.3 for the Crh120/+ bone and determined, respectively, the
late the angular distribution of the laminate for the Crh+/+ bone. Its FWHM was
l area. As a result, we adopted an angular distribution with 74% of 0, 24% of ±30 and
rocess led to the following angular distribution for the GIOP case: 64% of 0, 30% of
ata (see also Fig. 5A) the aspect ratios (AR) for the Crh+/+ and Crh120/+ bones were
id-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
Fig. 3. Tissue and fibrillar level mechanics: (A–D) Tissue level stress plotted as a function of fibril strain for femoral cortical bone from Crh120/+ and Crh+/+ mice aged (A) 8
weeks, (B) 12 weeks, (C) 24 weeks and (D) 36 weeks. Straight lines are linear regressions (solid black: Crh+/+; dashed gray: Crh120/+) (E) Tissue level modulus (GPa) plotted as a
function of genotype and developmental age. (F) Effective fibril modulus (GPa) plotted as a function of genotype and developmental age. (G) Maximum stress (MPa) plotted as
a function of genotype and developmental age. (H) Maximum fibril strain (%) plotted as a function of genotype and developmental age. Error bars shown are standard
deviations. Student’s t-tests were performed to determine if there are statistical significance in the differences between effective fibril modulus, maximum fibril strain, tissue
modulus, and maximum stress between Crh+/+ and Crh120/+ mice at four developmental ages. Statistical significance is denoted (*p < 0.05, **p < 0.01, ***p < 0.001, ns: not
significant).
L. Xi et al. / Acta Biomaterialia xxx (2018) xxx–xxx 7differences are between fibril modulus at 36 weeks versus fibril
modulus at 8, 12 and 24 weeks (Table S3, Supplementary Informa-
tion). The maximum fibrillar strain was significantly higher in
Crh120/+ mice compared to Crh+/+ mice at 36 weeks (p < 0.05),
but not at other age points (Fig. 3H).
Tissue level modulus as a function of genotype and age was
plotted in Fig. 3E. Tissue modulus were lower in Crh120/+ bone
compared to Crh+/+ bone, with significant difference for mice at
12 (p < 0.001), 24 (p < 0.01) and 36 weeks (p < 0.01), but not for
mice at 8 weeks (p > 0.05). There is a statistically significant differ-
ence in tissue modulus across 4 ages in both Crh+/+ (p < 0.001) and
Crh120/+ mice (p < 0.01). In Crh+/+ mice, tissue modulus at 36
weeks is significantly different from tissue modulus at 8 and 12
weeks, and tissue modulus at 8 weeks is significantly different
from tissue modulus at 24 weeks. In Crh120/+ mice, tissue modulusPlease cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/at 8 weeks is significantly different from tissue modulus at 24 and
36 weeks. For further details, refer to Table S4, Supplementary
Information. Maximum stresses were significantly higher in
Crh+/+ bone compared to Crh120/+ bone at 12 weeks (p < 0.001),
24 weeks (p < 0.01) and 36 weeks (p < 0.001), while the difference
was not significant at 8 weeks (Fig. 3G).
3.2. BSE imaging and X-ray microtomography
BSE images (Fig. 4A) were acquired on polished cross sections of
tibia mid-diaphysis to examine possible mineralization defects in
Crh120/+ mice. A striking difference in cortical microstructure
between the Crh120/+ and Crh+/+ mice was observed at all four ages.
As reported in prior histochemical studies on this model [34], the
endosteal surface for Crh120/+ mice has a surface which has ruffledid-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
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bone, which is believed to arise from multiple factors: reduced
osteoblast coverage on the cortico-endosteal surface, lower num-
ber of osteoblasts and slower mineralizing rate. The overall cortical
thickness of Crh120/+ mice was smaller than Crh+/+ mice, and the
cross sections of Crh120/+ tibia had a very large fraction of cavities,Fig. 4. Tissue mineralization: (A) BSE images of transverse cross sections of tibia mid-d
weeks). (B) Transverse cross section of mid-shaft femora from Crh120/+ mice aged 24 wee
BSE image of longitudinal section of mid-shaft femora from Crh+/+ (upper) and Crh120/+ m
X-ray tomography images of transverse cross section of mid-shaft femora from Crh+/+, Crh
mineral concentration as a function of developmental ages for Crh+/+, Crh120/+ periosteal r
of development age (weeks) for Crh+/+ (black circles) and Crh120/+ mice (red triangles (co
standard deviations. Statistical significance is denoted (*p < 0.05, **p < 0.01, ***p < 0.00
legend, the reader is referred to the web version of this article.)
Please cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/particularly near the endosteal cortex, leading to an increased
porosity. We note also that the distribution of cavities around
the circumference of the tibiae is not uniform. In contrast, Crh+/+
tibia had a denser cortical cross-section and showed uniformly
distributed lacunae around the full cortex. Fig. 4B shows a high
magnification of transverse cross section of mid-shaft femora fromiaphysis from Crh+/+ and Crh120/+ mice bone with different ages (8, 12, 24 and 36
ks. Periosteal region and endosteal region with halos (dashed line) are indicated. (C)
ice (lower) aged 24 weeks. (D) Histograms of mineral concentration obtained from
120/+ bone, and Crh120/+ periosteal and endosteal regions aged 24 weeks. (E) Mean
egions and Crh120/+ endosteal regions. (F) Meanmineral concentration as a function
lour online), including both periosteal and endosteal regions). Error bars shown are
1, ns: not significant). (For interpretation of the references to colour in this figure
id-induced osteoporosis is associated with a consistently reduced fibrillar
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L. Xi et al. / Acta Biomaterialia xxx (2018) xxx–xxx 9Crh120/+ mice aged 24 weeks, with periosteal and endosteal region
indicated on the figure. A BSE image of longitudinal section of mid-
shaft femora from Crh+/+ (upper) and Crh120/+ mice (lower) aged
24 weeks are shown in Fig. 4C. Again, there are many large cavities
near the endosteal cortex in Crh120/+ femora, whereas Crh+/+
femora showed uniformly distributed lacunae and no such cavities.
X-ray microtomography was used to measure the three-
dimensional morphology and mineral concentration of mid-shaft
femora. Microtomography of the mid-shaft femora used for the
in situ SAXD testing were used, rather than the tibial sections used
for BSE in Fig. 4A, in order to obtain the mineral concentration of
samples where fibril moduli has been determined, and to avoid
measurement errors from the angular anisotropy of the endosteal
cancellous-like structure. Fig. 4D shows plots of the tissue mineral
concentration obtained from X-ray tomography images of trans-
verse cross sections of mid-shaft femora from Crh+/+, Crh120/+
bone, and Crh120/+ periosteal and endosteal regions aged 24
weeks. We note that the mineral concentration refers to the bone
tissue alone, excluding all voids and spaces within the tissue.
The mean mineral concentrations (from X-ray microtomogra-
phy measurements) were plotted as a function of developmental
age for Crh+/+ mice, periosteal regions away from cavities and endo-
steal regions near cavities in Crh120/+ mice (Fig. 4E). Regarding the
data in Fig. 4E, one-way ANOVA tests showed that the mean min-
eral concentration in Crh+/+ mice, periosteal (Crh120/+-PR) and
endosteal regions (Crh120/+-ER) in Crh120/+ mice were similar at
8 weeks and the difference is not significant (p = 0.922). After 8
weeks, however, there are significant (p < 0.001) differences of
the mean mineral concentrations between these three groups
(Crh+/+, Crh120/+-PR, Crh120/+-ER) at 12, 24 and 36 weeks
(Table S2, Supplementary Information). As can be seen from this
table together with Fig. 4E, post-hoc tests showed that at 12 weeks,
Crh120/+-ER was significantly lower than both Crh120/+-PR (p =
0.003) and Crh+/+ (p < 0.001). Similarly, at 24 weeks, Crh120/+-ER
was significantly lower than both Crh120/+-PR (p = 0.001) and
Crh+/+ (p < 0.001), and at this age-point the difference between
Crh120/+-PR and Crh+/+ was also significant (p = 0.045). Lastly, at
36 weeks, Crh120/+-ER was also significantly lower than both
Crh120/+-PR (p < 0.001) and Crh+/+ (p < 0.001).
It is observed that the rate of increase in mineralization with
age was generally greater in Crh+/+ mice than in the Crh120/+-PR
regions in Crh120/+ mice, whereas the mean mineral concentration
decreased dramatically from 1.68 g/cm3 at 8 weeks to 1.46 g/
cm3 at 12 weeks and kept nearly constant after 12 weeks in the
Crh120/+-ER endosteal regions in Crh120/+ mice. Indeed, one-way
ANOVA tests shows that the variation with age was significant
(p < 0.001) for Crh+/+, significant (p = 0.021) for the endosteal region
of Crh120/+ (Crh120/+-ER), and nonsignificant (p = 0.053) for the
periosteal region of Crh120/+ (Crh120/+-PR). Considering the
Crh120/+-ER zone, Tukey’s post-hoc tests show (Table S1, Supple-
mentary Information) that the significant (p = 0.022) difference is
the drop between 8 and 12 weeks, in line with the qualitative
observation from BSE images that there are less halos and
hypomineralized regions in Crh120/+ endosteal regions at 8 weeks
compared to later time-points. For the Crh+/+ mice bone, Tukey’s
post-hoc tests (Table S1) show significant (p < 0.05) differences
between all ages, except between the last two age points (24 ver-
sus 36 weeks), characteristic of an initial rise in mineralization fol-
lowed by a levelling-off. These variations across four
developmental ages showed that the mineral concentration was
impaired over age in Crh120/+ mice as compared with Crh+/+ mice,
specifically in the cancellous-like tissue in the endosteal regions in
Crh120/+ mice.
Lastly, when the periosteal and endosteal regions are not sepa-
rately considered, and an average mineral concentration calculated
for Crh120/+ mice, Fig. 4F shows the meanmineral concentration asPlease cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/a function of development age (weeks) for Crh+/+ and Crh120/+
mice. In this case, Student’s t-tests showed significant differences
in the mean mineral concentrations between Crh+/+ and Crh120/+
mice at 12, 24 and 36 weeks. There is not a statistically significant
difference (p = 0.655) in the mean mineral concentrations across
the 4 ages in Crh120/+ bone as a whole.
3.3. Model results
The model described in Section 2.11 was used to compare the
effective fibril modulus (experimentally calculated) with the longi-
tudinal (along the direction of 0 laminae) stiffness of the whole
laminated (numerically calculated via lamination theory [57]). As
described in 2.11, using an average value of q of 0.45 for Crh+/+
bone and 0.3 for the Crh120/+ bone (from Fig. 6D), the equivalent
FWHM for each bone type was calculated to be 48 (Crh+/+) and
57 (Crh120/+) respectively. By discretizing the equivalent normal-
ized Gaussian curve, we obtain the relative proportions of fibrils in
different laminae (sublamellae) in the Bouligand structure. For
Crh+/+, we obtained 74% of 0 laminae, 24% of ±30 laminae and
2% of ±60 laminae, whilst (as expected) for Crh120/+ bone a
broader Gaussian distribution of 64% of 0 laminae, 30% of ±30
laminae and 6% of ±60 laminae were found. Fig. 2D shows the dis-
cretization for the case of Crh+/+ bone.
Numerical curves (Fig. 5A) were obtained by minimizing the
mean squared difference between the experimental Ef values (at
the measured values of mineral volume fraction) and the model
predictions for Ef. This best-fit process allowed us to estimate the
aspect ratio AR of mineral particles within mineralized fibrils in
Crh+/+ and Crh120/+ bone (15.0 and 9.6, respectively), as shown
schematically in Fig. 2E. The quality of the best fit was assessed
by a chi-squared test of the residual sum of squares (normalized
by the standard deviations) with v2 reaching minimal values at
15.0 (v2 = 4.36) and 9.6 (v2 = 0.82), respectively, for Crh+/+ and
Crh120/+ bone. The larger v2 for Crh+/+ reflects the fact that the
36-week experimental value lies well above the fit line.
We then used the model to create parametric maps for the fibril
modulus of bone (Fig. 5B), where the effective fibril modulus of
interest is determined for a certain range of the mineral volume
fraction and several values of mineral AR- and q-parameter values.
This graph could, in future, be used for an inverse calculation in
case the AR of mineral platelets and the q-parameter are known
and the effective fibril modulus and the mineral volume fraction
are desired as output.
3.4. L-parameter and lattice spacing of the mineral crystallites and q-
parameter
Motivated by the difference in AR – between Crh+/+ and Crh120/+
bone – predicted by the model, we analysed wide-angle X-ray
diffraction (WAXD) patterns on the bone types acquired with the
microfocus beam. We wished to determine if there was experi-
mental evidence for the lowered AR of the mineral crystallites.
Fig. S2 (Supplementary Information) shows typical 2D profiles of
the (0 0 2) reflection of HA in femur mid-diaphysis from Crh+/+
and Crh120/+ mice bone aged 12 weeks. The (0 0 2) reflections were
fitted with a Lorentzian profile to obtain the FWHM. When com-
paring groups at each age point, as shown in Fig. 6A the FWHM
in Crh120/+ mouse bone is significantly higher than in Crh+/+ mouse
bone at all ages (p < 0.001). Correspondingly the L-parameter in
Crh120/+ mouse bone is significantly lower than in Crh+/+ mouse
bone at all ages (Fig. 6B, p < 0.001). Finally, the lattice spacing
shows an overall increasing – but non-monotonic – trend for both
groups (Fig. 6C).
One-way ANOVA tests shows that there is a statistically signif-
icant variation of the three parameters – L-parameter, FWHM, andid-induced osteoporosis is associated with a consistently reduced fibrillar
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Fig. 5. Model results: A) Comparison between experimental data and numerical best fit curves. The bars indicate the standard deviation of experimental results. From the
best fit process two different values of AR (aspect ratio) were calculated: 15.0 for the Crh+/+ and 9.6 for the Crh120/+ case. B) Effective fibril modulus vs mineral volume fraction
as function of the aspect ratio AR of mineral platelets and q (level of alignment of mineral particles).
Fig. 6. Nanoscale structural parameters of bone mineral and fibrils: (A) FWHM of the (0 0 2) reflection of HA as a function of age for Crh+/+ and Crh120/+ bone at different ages.
(B) L-parameter and (C) lattice spacing of HA crystallite for Crh+/+ and Crh120/+ bone at different ages. (D) Degree of alignment of the mineral crystals (q-parameter) as a
function of age and disease condition. Error bars shown are standard deviations. Statistical significance is denoted (*p < 0.05, **p < 0.01, ***p < 0.001, ns: not significant).
10 L. Xi et al. / Acta Biomaterialia xxx (2018) xxx–xxxlattice spacing – from the (0 0 2) profiles across age-points in both
Crh+/+ and Crh120/+ groups (Tables S5–S7, Supplementary
Information). The difference is significant (p < 0.001) for all six
combinations (3 parameters and 2 bone types). Regarding the
L-parameter, it exhibits a decreasing tendency with age for thePlease cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/healthy Crh+/+ mouse, and an increasing trend for the Crh120/+
mouse. Post-hoc Tukey tests reveal (Table S7) that for Crh120/+
mouse bone, the first two age points are different from the last
two: specifically, there are significant differences (p < 0.001)
between 8- and 24-weeks, and between 12- and 24-weeks, andid-induced osteoporosis is associated with a consistently reduced fibrillar
/doi.org/10.1016/j.actbio.2018.05.053
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between 12- and 36 weeks. For the healthy Crh+/+ mouse bone, dif-
ferences between 8-weeks and all other age-points are significant
(p < 0.001). The FWHM, being proportional to the inverse of the
L-parameter (Materials and Methods), follows a similar pattern
(Table S7). For the (0 0 2) lattice parameter, post-hoc Tukey tests
show (Table S7) for Crh120/+ mouse bone a significant (p < 0.001)
difference between 8-weeks and all other age-points, a significant
(p < 0.001) difference between 12- and 24-weeks and a significant
(p = 0.014) difference between 12- and 36-weeks. The correspond-
ing post-hoc tests in the healthy Crh+/+ mouse bone find significant
differences (p < 0.001) between 8-weeks and both 12- and 36-
weeks, as well as between 12-weeks and both 24- and 36-weeks,
and significant (p = 0.005) differences between 24- and 36-weeks.
Lastly, q-parameters were plotted as a function of age and
disease condition in Fig. 6D. Student’s t-tests showed that
q-parameters are consistently significantly higher (p < 0.001) in
Crh+/+ than in Crh120/+ mice at age 12, 24 and 36 weeks, whereas
there is no significant difference between them at 8 weeks. Regard-
ing age-variation of the q-parameter, there is a monotonic decreas-
ing trend in Crh120/+ mice, which is significant (p < 0.001) across
ages (Table S8, Supplementary Information). Post-hoc testing
shows, for Crh120/+ mice, significant (p < 0.001) differences
between 8-weeks and both 24- and 36-weeks, and significant
differences (p = 0.027) between 12- and 24-weeks. Although the
q-parameter for Crh+/+ mice shows no monotonic trend, there are
also very significant (p = 0.002) differences between ages. In this
case, the 12-week point is significantly (p = 0.005) higher than
the 8-week values, and significantly (p = 0.002) higher than the
subsequently decreased values at 36-weeks.4. Discussion
In summary, our main findings are:
 Consistently reduced fibrillar modulus in Crh120/+ mouse bone
in comparison to Crh+/+ mouse bone, with minimal increase in
fibrillar modulus with age in Crh120/+ mouse bone, in contrast
to an over 2-fold increase in Crh+/+ mouse bone fibril modulus
(Fig. 3).
 A heterogeneous and lower mineralization density distribution
at the microscale, accompanied by a more porous 3D microar-
chitecture in Crh120/+ mouse bone (Fig. 4).
 A laminate fibril array model – based on the rotated plywood
lamella [56,59], and deriving its parameters from experimental
structural data – explains the reduced effective fibril modulus
(measured experimentally) in Crh120/+ mouse bone in compar-
ison to Crh+/+ mouse bone (Fig. 5).
 In terms of the model parameters, the main difference between
Crh120/+ and Crh+/+ is a reduced mineral platelet aspect ratio AR
(15.0 (Crh+/+) to 9.6 (Crh120/+)) at the scale of the mineralized
collagen fibril (Figs. 2 and 5).
 Reduced length of mineral platelets in Crh120/+ bone, as mea-
sured from the Debye-Scherrer width, consistent with the
reduced AR predicted by the model (Fig. 6).
 A greater degree of fibrillar disorganization (measured via the
q-parameter) in Crh120/+ bone compared to Crh+/+ (Fig. 6).
In terms of our hypothesis about alterations in the fibrillar
structure-function relations, the results provide clear evidence
for changes in fibrillar deformation mechanisms in Crh120/+ com-
pared to Crh+/+, which are consistent throughout development
(see, e.g. Fig. 3F). Concurrently, the degree of fibrillar disorganiza-
tion (given by the q-parameter) shows similar values between
Crh+/+ and Crh120/+ at the earliest time-point investigated (8Please cite this article in press as: L. Xi et al., Bone matrix development in stero
stiffness linked to altered bone mineral quality, Acta Biomater. (2018), https:/weeks) but a rapid decrease in the q-parameter in Crh120/+ relative
to Crh+/+ for all subsequent age-points (Fig. 6D). The experimental
(Figs. 3 and 4) and modelling (Fig. 5) results on the fibrillar defor-
mation provide evidence that the lowered overall mineralization
may also have an additional mechanically significant effect at the
fibrillar level, through the reinforcement of the collagen fibril via
the staggered arrangement of mineral and collagen. Therefore,
while bone microarchitecture and overall mineralization level is
important for the mechanical alteration in Crh120/+, so also is the
nanocomposite architecture.
The mineralized microstructure in Crh120/+ (Fig. 4A–C) shows a
distinct region on the endosteal side, resembling cancellous bone,
where lower overall mineral density and a porous microstructure
are found. Together with the structural normality of the periosteal
region, these results suggest the mechanistic effects in cortical
bone are solely due to this endosteal hypomineralized zone. Our
findings of a lowered L-parameter, and a reduced aspect ratio AR
in the model, makes it clear that the ultrastructural bone mineral
shape, as well as its overall volume fraction, is mechanically impor-
tant both at the nano- and macro-length scales. This is due to the
shorter mineral platelets in Crh120/+ (lower AR) having a reduced
mechanical reinforcing efficiency in the collagen matrix. Prior sim-
ulation and experimental work on the mineralized collagen fibril
have emphasized the importance of the mineral platelet structural
anisotropy (e.g. [17,52,54,55]).
This heterogeneous mineralized matrix structure is likely cre-
ated by the alteration in cellular activity in GIOP [1]. Consistent
with prior work on osteoclast activation, osteoblast suppression
and trench-like cavities formed in GIOP bone [10,25], the endosteal
cortical bone in the Crh120/+ model exhibits extensive excavation
of elongated cavities. The mineralization in the endosteal region
is, on average, characteristic of less mature tissue and even, quan-
titatively, to hypomineralized conditions like osteomalacia [60]. It
is also possible, although this cannot be confirmed with the current
data alone, that the proposed ‘‘osteolytic osteolysis” mechanism is
involved in the overall lower mineralization, due to leaching of
mineral from around osteocyte lacunae [61]. Our prior high magni-
fication electron microscopy images on Crh120/+ mouse bone [32]
showed haloes of lower mineralized tissue around the porous
endosteal tissue. Future scanning microbeam X-ray scattering
and diffraction measurements around such cavities may shed light
on the dynamics of mineralized tissue formation in Crh120/+.
The model of the mineralized fibrils presented here, containing
anisometric mineral platelets, highlights the importance of the
nanoscale architecture in the stiffness. The multiscale model
presented here is similar to the fibril/lamellar models presented
earlier for bone (e.g. [52,54,55,62–64]). At the scale of the fibril,
the deformation in the bone matrix operates via a shearing in the
collagen layers combined with a mainly tensile load in the mineral
platelets. Load transfer between collagen and mineral is facilitated
by the long aspect ratio of the platelets, resulting in large interfa-
cial area of contact between the two phases for shear transfer. As
a result, beyond a simple rule of mixtures for the mineral and col-
lagen, a staggered model of the mineralized fibrils means that the
overall tissue modulus depends on AR via Eqs. (5) and (9) in the
Supplementary Information [55]. Therefore, variations in AR will
have considerable effects on the modulus. It is assumed that the
interfibrillar matrix contributes negligibly to the overall stress here
(due to its very small volume fraction 2–5%[17,55]). Hence, the
stress on the fibrillar-phase in tension is the majority of stress on
the bone matrix (rT =U1 rF + (1 U1) rIF – rF; rT tissue stress,
rF fibril stress; rIF interfibrillar matrix stress, and U1 – 1 is fibril
volume fraction). As a result, the fibril modulus – under these
assumptions – is a good proxy for the tissue modulus at the mate-
rial level (after correction for microscale porosity). In relation to
prior multiscale staggered models (e.g. [52–55,62,63]), in theid-induced osteoporosis is associated with a consistently reduced fibrillar
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12 L. Xi et al. / Acta Biomaterialia xxx (2018) xxx–xxxpresent work we incorporate, from experimental data, structural
parameters from motifs like the plywood structure (such as their
angular widths). The second is the comparison of deformation
mechanisms between model and experiment at multiple scales
rather than at the macroscopic tissue level only.
Some technical limitations and assumptions of the current work
are noted. Due to the transmission nature of the SAXD/WAXDmea-
surements, all nano- and molecular-level information is integrated
across a scattering volume in the form of a tunnel with diameter
10 lm and length 200 lm going through the periosteal and
endosteal regions. This means that the lowered fibrillar modulus
and increased WAXD peak width is a weighted average of ultra-
structural information from the endosteal region (lowered miner-
alization) and the periosteal region (Fig. 4B). Therefore, the actual
ultrastructure in the bone matrix region most affected (endosteal
region) is likely to be even more deviant from healthy bone. Sec-
ondly, the porous microarchitecture is not integrated fully into
the multiscale model, and appears as a correction to the stress
only. The application of multiscale models including porosity at
different levels, as in [65], would be beneficial in this regard.
Finally, it was assumed that the basic building block of the
microstructural level (the lamella) is similar between Crh120/+
and Crh+/+, and only distributed differently across the tissue zones.
In conclusion, combined ultrastructural nanomechanical
experiments and modelling analysis have been carried out to
determine the mechanical differences between murine bone with
glucocorticoid-induced osteoporosis and healthy bone, as a func-
tion of tissue age and development. It is suggested that the combi-
nation of an altered mineral nanostructure together with overall
lower mineralization and fibrillar disorganization is the major fac-
tor behind both the lowered fibrillar mechanical properties and the
lack of increase of fibrillar modulus with age in Crh120/+. The
combination of fibrillar-level deformation via X-ray diffraction,
together with analytical modelling, helps to provide a self-
consistent check of how the effects of alterations at the nano-
and microscale propagate up the levels of structural hierarchy in
bone. Such an approach will be useful in understanding the
relevant nanostructural changes, mediated by biological activity,
that alter or cause deterioration in musculoskeletal function in
bone and cartilage disorders.
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